Latest news
AXSM Stock Advances on CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030 - TradingViewTradingView · Mon, 10 Aug 2026 18:51:23 GMTPraxis Precision Medicines gains as investors refocus on late-stage CNS pipeline and upcoming FDA catalysts - quiverquant.comquiverquant.com · Thu, 06 Aug 2026 16:31:00 GMTVertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says - MoomooMoomoo · Tue, 04 Aug 2026 17:05:15 GMT